Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT00510601

Treating Congestive Heart Failure Using a Device to Remove Cholesterol

LDL Apheresis for the Treatment of Congestive Heart Failure

Sponsor: Kaneka Medical America LLC

Updated 7 times since 2017 Last updated: Jan 12, 2016 Started: Jul 31, 2007 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Heart Decompensation, this trial is completed. The trial is conducted by Kaneka Medical America LLC and has accumulated 7 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Oct 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Oct 2021 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaneka Medical America LLC
Patrick Moriarty, MD, FACP, FACC

Data source: University of Kansas Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States